Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.11 | 13.80 |
| PEG Ratio (TTM) | -0.43 | 7.53 |
| P/S Ratio (TTM) | 1.54 | 3.32 |
| P/B Ratio (TTM) | 1.16 | 1.41 |
| P/FCF Ratio (TTM) | 1.65 | -77.28 |
| Price to 5YR AVG Earnings Ratio | 8.84 | 33.68 |
| Price to 5YR AVG FCF Ratio | 1.54 | 29.05 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.43% | 0.88% |
| ROE (TTM) | 7.84% | 10.65% |
| Net Profit Margin (TTM) | 10.16% | 24.79% |
| ROIC 5YR AVG | 7.02% | 14.03% |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 279.08% | 15.19% | -1.76% |
| Revenue | 12.12% | 4.06% | 6.68% |
| Net Income | 497.47% | 14.68% | -2.42% |
| Cash Flow | 119.66% | 28,175.12% | 16,888.37% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | 5.79 |
| Quick Ratio (TTM) | N/A | 5.79 |
| D/E Ratio (TTM) | 3.96 | 1.43 |
| Interest Coverage (TTM) | 0.01 | 0.60 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 0.35 | 0.48 |
| LTL to 5YR AVG FCF | 3.48 | 12.95 |
| Shares Outstanding Growth 5YR AVG | -0.61% | 0.73% |